Eupraxia Pharmaceuticals (EPRX) Stock Chart & Stock Price History $3.18 +0.12 (+3.92%) (As of 12/26/2024 05:41 PM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Eupraxia Pharmaceuticals Stock Price Performance 5 Day Performance+6.35%1 Month Performance-7.83%3 Month Performance+20.91%6 Month Performance+24.22% Receive EPRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address AI breakthrough about to upend industry (Ad)Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing.I urge you to watch it now. EPRX Stock Chart for Friday, December, 27, 2024 EPRX Chart by TradingView Eupraxia Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/26/2024$3.06$3.18+3.92%$3.21$2.8911,825 shs$86.76 million12/25/2024$3.06$3.06$3.06$3.06314 shs$83.48 million12/24/2024$3.09$3.06-0.97%$3.06$3.06314 shs$83.48 million12/23/2024$2.99$3.09+3.34%$3.12$2.907,212 shs$84.30 million12/20/2024$3.00$2.99-0.33%$3.07$2.767,778 shs$81.57 million12/19/2024$3.19$3.00-5.96%$3.18$2.988,718 shs$81.85 million Get the Latest News and Ratings for EPRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/18/2024$3.30$3.19-3.33%$3.43$3.1814,359 shs$87.03 million12/17/2024$3.44$3.30-4.07%$3.45$3.3015,531 shs$90.03 million12/16/2024$3.44$3.44-0.09%$3.50$3.317,415 shs$93.85 million12/13/2024$3.38$3.44+1.78%$3.45$3.335,053 shs$93.85 million12/12/2024$3.45$3.38-2.03%$3.45$3.2614,717 shs$92.21 million12/11/2024$3.27$3.45+5.50%$3.45$3.194,335 shs$94.12 million12/10/2024$3.32$3.27-1.51%$3.49$3.213,705 shs$89.21 million12/09/2024$3.12$3.32+6.41%$3.42$3.1916,507 shs$90.58 million12/06/2024$3.17$3.12-1.58%$3.23$3.1113,011 shs$85.12 million12/05/2024$3.15$3.17+0.63%$3.38$2.9619,532 shs$86.48 million12/04/2024$3.25$3.15-3.08%$3.28$2.968,526 shs$85.93 million12/03/2024$3.40$3.25-4.41%$3.39$3.1515,672 shs$88.66 million12/02/2024$3.35$3.40+1.49%$3.40$3.2923,467 shs$92.76 million11/29/2024$3.45$3.35-2.90%$3.63$3.3211,170 shs$91.39 million11/28/2024$3.45$3.45$3.56$3.065,693 shs$94.12 million11/27/2024$3.05$3.45+13.11%$3.56$3.065,693 shs$94.12 million11/26/2024$3.41$3.05-10.56%$3.57$3.0514,831 shs$83.20 million Related Companies Cryoport Stock Chart Design Therapeutics Stock Chart Procaps Group Stock Chart biote Stock Chart Neurogene Stock Chart Voyager Therapeutics Stock Chart Contineum Therapeutics Stock Chart Acelyrin Stock Chart Kamada Stock Chart Trevi Therapeutics Stock Chart Receive EPRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EPRX) was last updated on 12/27/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Eupraxia Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Eupraxia Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
